Eye On Delta, Sanofi/GSK To Begin India Trials Of COVID-19 Vaccine
Pfizer/BioNTech Look At Booster Shots
Sanofi and GSK, which are in the middle of Phase III global trials for their COVID-19 vaccine candidate, plan to test the contender against all variants of concern including the highly contagious Delta variant, Scrip has learned. Meanwhile, Pfizer/BioNTech is looking at a booster to combat lower efficacy/effectiveness against this variant.
